Bipolar Disorders Treatment Market 2027 By Type, Medication, Treatment and Geography | The Insight Partners

Bipolar Disorders Treatment Market to 2027 - Global Analysis and Forecasts by Type (Bipolar I, Bipolar II, Cyclothymia); Medication (Lithium, Anticonvulsants, Antipsychotics, Antidepressants, Anti-anxiety medications); Treatment (ECT (Electroconvulsive therapy), TMS (Transcranial magnetic stimulation), Others (Psychotic therapies)) and Geography

Report Code: TIPRE00004415 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Bipolar disorder, also known as manic depression, is a type of mental health condition which is associated with mood swings. Mood swings/ episodes are of two types: manic and depressive. The changes in the mental health causes sudden high or low moods in a person. A person suffering from bipolar disorder or maniac depression can be joyful, happy, and energized or sad and hopeless at the very next moment. Through rigorous research and development activities, scientists have discovered that certain genes cause the bipolar disorder. Family history of bipolar disorder is one of the major reason that causes such illness. Such kind of mood swings can spoil the image of the person at a school or work place or in the society.

MARKET DYNAMICS
Growing awareness about diagnosis and treatment of bipolar disorder, increasing acceptance of society regarding mental illness, technological advancement bipolar disorder diagnosis and increase in treatment options for genetic disorders are major factors driving the bipolar disorder treatment market. Furthermore, government initiatives such as launch of Bipolar Disorder Phenome Database, funded by the National Institute of Mental Health (NIMH). These factors has further contributed to the growth of the market. However, factors such as stringent regulatory frameworks, side effects of anticonvulsants, and limited number of approved anticonvulsants for the treatment are few factors may restrain the growth of the market.

MARKET SCOPE
The "Global Bipolar Disorders Treatment Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Bipolar Disorders Treatment market with detailed market segmentation by type, medication, treatment and geography. The global Bipolar Disorders Treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Bipolar Disorders Treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Bipolar Disorders Treatment market is segmented on the type, medication and treatment. On the basis of type, the global Bipolar Disorders Treatment market is segmented into Bipolar I, Bipolar II and Cyclothymia. On the basis of medication, the market is segmented into lithium, anticonvulsants, antipsychotics, antidepressants and anti-anxiety medications. On the basis of treatment, the bipolar disorder treatment market is segmented into ECT (Electroconvulsive therapy), TMS (Transcranial magnetic stimulation) and others (Psychotic therapies).
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Bipolar Disorders Treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Bipolar Disorders Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Bipolar Disorders Treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Bipolar Disorders Treatment market in these regions.

MARKET PLAYERS
The reports cover key developments in the Bipolar Disorders Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Bipolar Disorders Treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for Bipolar Disorders Treatment in the global market. Below mentioned is the list of few companies engaged in the Bipolar Disorders Treatment market.

The report also includes the profiles of key Bipolar Disorders Treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • AbbVie Inc.
  • AstraZeneca
  • Allergan Plc.
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Otsuka Holdings Co. Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bipolar Disorders Treatment Market - By Type
1.3.2 Bipolar Disorders Treatment Market - By Medication
1.3.3 Bipolar Disorders Treatment Market - By Treatment
1.3.4 Bipolar Disorders Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. BIPOLAR DISORDERS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIPOLAR DISORDERS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIPOLAR DISORDERS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. BIPOLAR DISORDERS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. BIPOLAR DISORDERS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BIPOLAR DISORDERS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. BIPOLAR I
7.3.1. Overview
7.3.2. Bipolar I Market Forecast and Analysis
7.4. BIPOLAR II
7.4.1. Overview
7.4.2. Bipolar II Market Forecast and Analysis
7.5. CYCLOTHYMIA
7.5.1. Overview
7.5.2. Cyclothymia Market Forecast and Analysis
8. BIPOLAR DISORDERS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - MEDICATION
8.1. OVERVIEW
8.2. MEDICATION MARKET FORECASTS AND ANALYSIS
8.3. LITHIUM
8.3.1. Overview
8.3.2. Lithium Market Forecast and Analysis
8.4. ANTICONVULSANTS
8.4.1. Overview
8.4.2. Anticonvulsants Market Forecast and Analysis
8.5. ANTIPSYCHOTICS
8.5.1. Overview
8.5.2. Antipsychotics Market Forecast and Analysis
8.6. ANTIDEPRESSANTS
8.6.1. Overview
8.6.2. Antidepressants Market Forecast and Analysis
8.7. ANTI-ANXIETY MEDICATIONS
8.7.1. Overview
8.7.2. Anti-anxiety medications Market Forecast and Analysis
9. BIPOLAR DISORDERS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. ECT (ELECTROCONVULSIVE THERAPY)
9.3.1. Overview
9.3.2. ECT (Electroconvulsive therapy) Market Forecast and Analysis
9.4. TMS (TRANSCRANIAL MAGNETIC STIMULATION)
9.4.1. Overview
9.4.2. TMS (Transcranial magnetic stimulation) Market Forecast and Analysis
9.5. OTHERS (PSYCHOTIC THERAPIES).
9.5.1. Overview
9.5.2. Others (Psychotic therapies). Market Forecast and Analysis
10. BIPOLAR DISORDERS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Bipolar Disorders Treatment Market Overview
10.1.2 North America Bipolar Disorders Treatment Market Forecasts and Analysis
10.1.3 North America Bipolar Disorders Treatment Market Forecasts and Analysis - By Type
10.1.4 North America Bipolar Disorders Treatment Market Forecasts and Analysis - By Medication
10.1.5 North America Bipolar Disorders Treatment Market Forecasts and Analysis - By Treatment
10.1.6 North America Bipolar Disorders Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Bipolar Disorders Treatment Market
10.1.6.1.1 United States Bipolar Disorders Treatment Market by Type
10.1.6.1.2 United States Bipolar Disorders Treatment Market by Medication
10.1.6.1.3 United States Bipolar Disorders Treatment Market by Treatment
10.1.6.2 Canada Bipolar Disorders Treatment Market
10.1.6.2.1 Canada Bipolar Disorders Treatment Market by Type
10.1.6.2.2 Canada Bipolar Disorders Treatment Market by Medication
10.1.6.2.3 Canada Bipolar Disorders Treatment Market by Treatment
10.1.6.3 Mexico Bipolar Disorders Treatment Market
10.1.6.3.1 Mexico Bipolar Disorders Treatment Market by Type
10.1.6.3.2 Mexico Bipolar Disorders Treatment Market by Medication
10.1.6.3.3 Mexico Bipolar Disorders Treatment Market by Treatment
10.2. EUROPE
10.2.1 Europe Bipolar Disorders Treatment Market Overview
10.2.2 Europe Bipolar Disorders Treatment Market Forecasts and Analysis
10.2.3 Europe Bipolar Disorders Treatment Market Forecasts and Analysis - By Type
10.2.4 Europe Bipolar Disorders Treatment Market Forecasts and Analysis - By Medication
10.2.5 Europe Bipolar Disorders Treatment Market Forecasts and Analysis - By Treatment
10.2.6 Europe Bipolar Disorders Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Bipolar Disorders Treatment Market
10.2.6.1.1 Germany Bipolar Disorders Treatment Market by Type
10.2.6.1.2 Germany Bipolar Disorders Treatment Market by Medication
10.2.6.1.3 Germany Bipolar Disorders Treatment Market by Treatment
10.2.6.2 France Bipolar Disorders Treatment Market
10.2.6.2.1 France Bipolar Disorders Treatment Market by Type
10.2.6.2.2 France Bipolar Disorders Treatment Market by Medication
10.2.6.2.3 France Bipolar Disorders Treatment Market by Treatment
10.2.6.3 Italy Bipolar Disorders Treatment Market
10.2.6.3.1 Italy Bipolar Disorders Treatment Market by Type
10.2.6.3.2 Italy Bipolar Disorders Treatment Market by Medication
10.2.6.3.3 Italy Bipolar Disorders Treatment Market by Treatment
10.2.6.4 Spain Bipolar Disorders Treatment Market
10.2.6.4.1 Spain Bipolar Disorders Treatment Market by Type
10.2.6.4.2 Spain Bipolar Disorders Treatment Market by Medication
10.2.6.4.3 Spain Bipolar Disorders Treatment Market by Treatment
10.2.6.5 United Kingdom Bipolar Disorders Treatment Market
10.2.6.5.1 United Kingdom Bipolar Disorders Treatment Market by Type
10.2.6.5.2 United Kingdom Bipolar Disorders Treatment Market by Medication
10.2.6.5.3 United Kingdom Bipolar Disorders Treatment Market by Treatment
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Bipolar Disorders Treatment Market Overview
10.3.2 Asia-Pacific Bipolar Disorders Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Bipolar Disorders Treatment Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Bipolar Disorders Treatment Market Forecasts and Analysis - By Medication
10.3.5 Asia-Pacific Bipolar Disorders Treatment Market Forecasts and Analysis - By Treatment
10.3.6 Asia-Pacific Bipolar Disorders Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Bipolar Disorders Treatment Market
10.3.6.1.1 Australia Bipolar Disorders Treatment Market by Type
10.3.6.1.2 Australia Bipolar Disorders Treatment Market by Medication
10.3.6.1.3 Australia Bipolar Disorders Treatment Market by Treatment
10.3.6.2 China Bipolar Disorders Treatment Market
10.3.6.2.1 China Bipolar Disorders Treatment Market by Type
10.3.6.2.2 China Bipolar Disorders Treatment Market by Medication
10.3.6.2.3 China Bipolar Disorders Treatment Market by Treatment
10.3.6.3 India Bipolar Disorders Treatment Market
10.3.6.3.1 India Bipolar Disorders Treatment Market by Type
10.3.6.3.2 India Bipolar Disorders Treatment Market by Medication
10.3.6.3.3 India Bipolar Disorders Treatment Market by Treatment
10.3.6.4 Japan Bipolar Disorders Treatment Market
10.3.6.4.1 Japan Bipolar Disorders Treatment Market by Type
10.3.6.4.2 Japan Bipolar Disorders Treatment Market by Medication
10.3.6.4.3 Japan Bipolar Disorders Treatment Market by Treatment
10.3.6.5 South Korea Bipolar Disorders Treatment Market
10.3.6.5.1 South Korea Bipolar Disorders Treatment Market by Type
10.3.6.5.2 South Korea Bipolar Disorders Treatment Market by Medication
10.3.6.5.3 South Korea Bipolar Disorders Treatment Market by Treatment
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Bipolar Disorders Treatment Market Overview
10.4.2 Middle East and Africa Bipolar Disorders Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Bipolar Disorders Treatment Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Bipolar Disorders Treatment Market Forecasts and Analysis - By Medication
10.4.5 Middle East and Africa Bipolar Disorders Treatment Market Forecasts and Analysis - By Treatment
10.4.6 Middle East and Africa Bipolar Disorders Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Bipolar Disorders Treatment Market
10.4.6.1.1 South Africa Bipolar Disorders Treatment Market by Type
10.4.6.1.2 South Africa Bipolar Disorders Treatment Market by Medication
10.4.6.1.3 South Africa Bipolar Disorders Treatment Market by Treatment
10.4.6.2 Saudi Arabia Bipolar Disorders Treatment Market
10.4.6.2.1 Saudi Arabia Bipolar Disorders Treatment Market by Type
10.4.6.2.2 Saudi Arabia Bipolar Disorders Treatment Market by Medication
10.4.6.2.3 Saudi Arabia Bipolar Disorders Treatment Market by Treatment
10.4.6.3 U.A.E Bipolar Disorders Treatment Market
10.4.6.3.1 U.A.E Bipolar Disorders Treatment Market by Type
10.4.6.3.2 U.A.E Bipolar Disorders Treatment Market by Medication
10.4.6.3.3 U.A.E Bipolar Disorders Treatment Market by Treatment
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Bipolar Disorders Treatment Market Overview
10.5.2 South and Central America Bipolar Disorders Treatment Market Forecasts and Analysis
10.5.3 South and Central America Bipolar Disorders Treatment Market Forecasts and Analysis - By Type
10.5.4 South and Central America Bipolar Disorders Treatment Market Forecasts and Analysis - By Medication
10.5.5 South and Central America Bipolar Disorders Treatment Market Forecasts and Analysis - By Treatment
10.5.6 South and Central America Bipolar Disorders Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Bipolar Disorders Treatment Market
10.5.6.1.1 Brazil Bipolar Disorders Treatment Market by Type
10.5.6.1.2 Brazil Bipolar Disorders Treatment Market by Medication
10.5.6.1.3 Brazil Bipolar Disorders Treatment Market by Treatment
10.5.6.2 Argentina Bipolar Disorders Treatment Market
10.5.6.2.1 Argentina Bipolar Disorders Treatment Market by Type
10.5.6.2.2 Argentina Bipolar Disorders Treatment Market by Medication
10.5.6.2.3 Argentina Bipolar Disorders Treatment Market by Treatment
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BIPOLAR DISORDERS TREATMENT MARKET, KEY COMPANY PROFILES
12.1. ABBVIE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTRAZENECA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ALLERGAN PLC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BRISTOL-MYERS SQUIBB
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GLAXOSMITHKLINE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JANSSEN PHARMACEUTICALS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MERCK AND CO., INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NOVARTIS AG
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PFIZER INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. OTSUKA HOLDINGS CO. LTD.
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AbbVie Inc.
2. AstraZeneca
3. Allergan Plc.
4. Bristol-Myers Squibb
5. Eli Lilly and Company
6. GlaxoSmithKline
7. Janssen Pharmaceuticals
8. Merck & Co. , Inc.
9. Novartis AG
10. Pfizer Inc.
11. Otsuka Holdings Co. Ltd.